ORGANOGENESIS HOLDINGS INC. Capital Expenditures
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Capital Expenditures of $4.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.10M, a 69.76% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $3.15M, a 13.24% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $4.65M, a 38.41% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.23M, a 13.00% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $14.15M, a 41.06% increase from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $10.03M, a 58.82% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $24.36M, a 28.13% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. payments to acquire property, plant, and equipment for fiscal 2022 was $33.90M, a 8.58% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.25M 10-Q · filed 2026-08-06 | $8.90M derived: sum of 3 quarters · filed 2026-08-06 | $11.13M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $3.15M 10-Q · filed 2026-05-07 | $7.80M derived: sum of 2 quarters · filed 2026-05-07 | $10.03M derived: sum of 3 quarters · filed 2026-05-07 | $13.67M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.89M derived: sum of 2 quarters · filed 2026-02-26 | $10.53M derived: sum of 3 quarters · filed 2026-08-06 | $14.15M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.87M derived: sum of 2 quarters · filed 2026-08-06 | $9.50M 10-Q · filed 2025-11-06 | $12.86M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $3.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.26M 10-Q · filed 2026-08-06 | $10.63M derived: sum of 3 quarters · filed 2026-08-06 | $13.19M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $3.63M 10-Q · filed 2026-05-07 | $6.99M derived: sum of 2 quarters · filed 2026-05-07 | $9.56M derived: sum of 3 quarters · filed 2026-05-07 | $11.44M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.93M derived: sum of 2 quarters · filed 2026-02-26 | $7.81M derived: sum of 3 quarters · filed 2026-02-26 | $10.03M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.45M derived: sum of 2 quarters · filed 2025-11-06 | $6.67M 10-Q · filed 2025-11-06 | $9.99M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.10M 10-Q · filed 2025-08-07 | $7.43M derived: sum of 3 quarters · filed 2026-02-26 | $13.40M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $2.22M 10-Q · filed 2025-05-08 | $5.55M derived: sum of 2 quarters · filed 2026-02-26 | $11.53M derived: sum of 3 quarters · filed 2026-02-26 | $19.02M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.30M derived: sum of 2 quarters · filed 2026-02-26 | $16.80M derived: sum of 3 quarters · filed 2026-02-26 | $24.36M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $5.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $13.48M derived: sum of 2 quarters · filed 2024-11-12 | $21.04M 10-Q · filed 2024-11-12 | $31.70M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $15.06M 10-Q · filed 2024-08-08 | $25.72M derived: sum of 3 quarters · filed 2025-02-27 | $36.12M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $7.56M 10-Q · filed 2024-05-09 | $18.22M derived: sum of 2 quarters · filed 2025-02-27 | $28.62M derived: sum of 3 quarters · filed 2025-02-27 | $34.79M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $21.06M derived: sum of 2 quarters · filed 2025-02-27 | $27.23M derived: sum of 3 quarters · filed 2025-02-27 | $33.90M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $10.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $16.57M derived: sum of 2 quarters · filed 2023-11-09 | $23.24M 10-Q · filed 2023-11-09 | $28.47M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $6.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $12.84M 10-Q · filed 2023-08-09 | $18.07M derived: sum of 3 quarters · filed 2024-02-29 | $34.77M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $6.67M 10-Q · filed 2023-05-10 | $11.90M derived: sum of 2 quarters · filed 2024-02-29 | $28.60M derived: sum of 3 quarters · filed 2024-02-29 | $32.94M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $21.93M derived: sum of 2 quarters · filed 2024-02-29 | $26.26M derived: sum of 3 quarters · filed 2024-02-29 | $31.22M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $16.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $21.04M derived: sum of 2 quarters · filed 2022-11-09 | $25.99M 10-Q · filed 2022-11-09 | $31.41M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $9.29M 10-Q · filed 2022-08-09 | $14.71M derived: sum of 3 quarters · filed 2023-03-01 | $20.56M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $4.96M 10-Q · filed 2022-05-10 | $10.38M derived: sum of 2 quarters · filed 2023-03-01 | $16.22M derived: sum of 3 quarters · filed 2023-03-01 | $18.39M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $11.27M derived: sum of 2 quarters · filed 2023-03-01 | $13.44M derived: sum of 3 quarters · filed 2023-03-01 | $17.68M 10-K · filed 2023-03-01 | $21.14M 10-K · filed 2021-03-16 |
| 2020-09-30 | $5.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $8.02M derived: sum of 2 quarters · filed 2021-11-09 | $12.26M 10-Q · filed 2021-11-09 | $15.72M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $6.41M 10-Q · filed 2021-08-09 | $9.87M derived: sum of 3 quarters · filed 2022-03-01 | $11.14M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $4.24M 10-Q · filed 2021-05-11 | $7.70M derived: sum of 2 quarters · filed 2022-03-01 | $8.98M derived: sum of 3 quarters · filed 2022-03-01 | $9.91M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.73M derived: sum of 2 quarters · filed 2022-03-01 | $5.67M derived: sum of 3 quarters · filed 2022-03-01 | $5.98M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.21M derived: sum of 2 quarters · filed 2020-11-09 | $2.53M 10-Q · filed 2020-11-09 | $2.89M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-06-30 | $934.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.25M 10-Q · filed 2020-08-10 | $1.61M derived: sum of 3 quarters · filed 2021-03-16 | $2.55M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-03-31 | $317.00K 10-Q · filed 2020-05-11 | $679.00K derived: sum of 2 quarters · filed 2021-03-16 | $1.62M derived: sum of 3 quarters · filed 2021-03-16 | $2.11M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | $362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.30M derived: sum of 2 quarters · filed 2021-03-16 | $1.79M derived: sum of 3 quarters · filed 2021-03-16 | $1.86M 10-K · filed 2021-03-16 | |
| 2018-09-30 | $938.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.43M derived: sum of 2 quarters · filed 2019-11-12 | $1.50M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $492.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $557.00K 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $65.00K 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $2.43M 10-K · filed 2020-03-09 | ||||
| 2016-12-31 | $1.36M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |